Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

NCT01066195 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: iressa
DRUG: alimta

Sponsor

Samsung Medical Center